X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1696) 1696
Publication (105) 105
Newsletter (64) 64
Book Review (29) 29
Book Chapter (27) 27
Book / eBook (13) 13
Conference Proceeding (10) 10
Newspaper Article (9) 9
Dissertation (2) 2
Magazine Article (2) 2
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1275) 1275
index medicus (923) 923
urology & nephrology (655) 655
male (627) 627
female (595) 595
chronic kidney failure (535) 535
middle aged (484) 484
chronic kidney disease (461) 461
mortality (396) 396
hemodialysis (394) 394
kidney diseases (390) 390
aged (382) 382
chronic kidney-disease (358) 358
nephrology (328) 328
parathyroid hormone (318) 318
risk factors (316) 316
adult (309) 309
secondary hyperparathyroidism (288) 288
vitamin d (287) 287
kidney failure, chronic - complications (285) 285
hemodialysis-patients (284) 284
parathyroid hormone - blood (283) 283
kidney failure, chronic - therapy (267) 267
renal dialysis (259) 259
calcium (248) 248
chronic kidney disease-mineral and bone disorder - etiology (248) 248
medicine & public health (243) 243
renal insufficiency, chronic - complications (222) 222
vascular calcification (221) 221
dialysis (219) 219
chronic kidney disease-mineral and bone disorder - prevention & control (212) 212
research (207) 207
care and treatment (205) 205
hyperparathyroidism (204) 204
parathyroid-hormone (196) 196
calcium - blood (191) 191
renal osteodystrophy (184) 184
analysis (183) 183
calcification (176) 176
stage renal-disease (175) 175
health aspects (172) 172
phosphates (169) 169
animals (164) 164
dialysis patients (163) 163
osteoporosis (163) 163
renal dialysis - adverse effects (163) 163
phosphorus (155) 155
mineral metabolism (151) 151
treatment outcome (150) 150
medical research (145) 145
metabolism (142) 142
bone density (136) 136
kidney transplantation (136) 136
medicine, experimental (135) 135
patients (135) 135
renal insufficiency, chronic - therapy (133) 133
endocrinology & metabolism (132) 132
phosphate (132) 132
phosphorus - blood (132) 132
risk (131) 131
calcifediol (130) 130
bone diseases (129) 129
hyperparathyroidism, secondary - etiology (128) 128
alfacalcidol (127) 127
transplantation (125) 125
vitamin-d (125) 125
glomerular filtration rate (124) 124
kidneys (124) 124
medicine (124) 124
phosphates - blood (124) 124
cardiovascular-disease (123) 123
research article (123) 123
biomarkers - blood (121) 121
bone (119) 119
cardiovascular disease (116) 116
vitamin d - therapeutic use (116) 116
fractures (115) 115
physiological aspects (115) 115
aged, 80 and over (113) 113
child (113) 113
prospective studies (111) 111
chronic kidney disease-mineral and bone disorder - drug therapy (108) 108
pediatrics (108) 108
renal insufficiency, chronic - blood (108) 108
adolescent (106) 106
cardiovascular diseases (106) 106
chronic kidney disease-mineral and bone disorder - therapy (106) 106
hyperphosphatemia (104) 104
kidney failure, chronic - blood (104) 104
calcium - metabolism (103) 103
chronic kidney disease-mineral and bone disorder - metabolism (101) 101
studies (99) 99
prevalence (98) 98
chronic kidney disease-mineral and bone disorder - diagnosis (97) 97
disease (96) 96
complications and side effects (93) 93
retrospective studies (92) 92
peritoneal dialysis (91) 91
bone mineral density (90) 90
chronic-renal-failure (90) 90
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1676) 1676
Japanese (29) 29
German (20) 20
French (19) 19
Spanish (16) 16
Italian (14) 14
Polish (8) 8
Czech (3) 3
Chinese (2) 2
Croatian (2) 2
Finnish (2) 2
Korean (1) 1
Russian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2018, Volume 2018, Issue 8, p. CD006023
Background Phosphate binders are used to reduce positive phosphate balance and to lower serum phosphate levels for people with chronic kidney disease (CKD)... 
Bone Diseases | Metabolic [drug therapy | prevention & control]; Calcium [blood | JAPANESE HEMODIALYSIS-PATIENTS | Phosphorus [blood] | Calcium Compounds [adverse effects; therapeutic use] | RANDOMIZED CLINICAL-TRIAL | PERITONEAL-DIALYSIS PATIENTS | Parathyroid Hormone [blood] | Randomized Controlled Trials as Topic | Hypercalcemia [chemically induced] | MEDICINE, GENERAL & INTERNAL | PARATHYROID-HORMONE LEVELS | CORONARY-ARTERY CALCIFICATION | Polyamines [adverse effects; therapeutic use] | Sevelamer Humans | GROWTH-FACTOR 23 | ORAL FERRIC CITRATE | PLACEBO-CONTROLLED TRIAL | Kidney Diseases [blood; complications] | Chronic Disease | Chelating Agents [adverse effects; therapeutic use] | CHRONIC-RENAL-FAILURE | CALCIUM ACETATE/MAGNESIUM CARBONATE | Chronic Kidney Disease-Mineral and Bone Disorder - blood | Polyamines - adverse effects | Humans | Middle Aged | Polyamines - therapeutic use | Parathyroid Hormone - blood | Cause of Death | Sevelamer - therapeutic use | Calcium - blood | Calcium Compounds - adverse effects | Calcium Compounds - therapeutic use | Chronic Kidney Disease-Mineral and Bone Disorder - prevention & control | Adult | Iron Compounds - therapeutic use | Chelating Agents - therapeutic use | Iron Compounds - adverse effects | Lanthanum - adverse effects | Lanthanum - therapeutic use | Chelating Agents - adverse effects | Renal Dialysis - statistics & numerical data | Hypercalcemia - chemically induced | Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy | Disease Progression | Phosphorus - blood | Aged
Journal Article
Kidney International, ISSN 0085-2538, 01/2018, Volume 93, Issue 1, pp. 147 - 158
We examined activin receptor type IIA (ActRIIA) activation in chronic kidney disease (CKD) by signal analysis and inhibition in mice with Alport syndrome using... 
cardiovascular disease | chronic kidney disease | bone | fibrosis | mineral metabolism | vascular calcification | TGF-BETA | CARDIOVASCULAR EVENTS | RENAL FIBROSIS | ARTERIAL CALCIFICATION | BONE MORPHOGENETIC PROTEIN-7 | GROWTH-FACTOR 23 | UROLOGY & NEPHROLOGY | SMOOTH-MUSCLE-CELLS | LINKED ALPORT-SYNDROME | OSTEOCLAST DIFFERENTIATION | ATHEROSCLEROTIC LESION | Kidney - pathology | Recombinant Fusion Proteins - pharmacology | Blood Vessels - metabolism | Chronic Kidney Disease-Mineral and Bone Disorder - metabolism | Core Binding Factor Alpha 1 Subunit - metabolism | Chronic Kidney Disease-Mineral and Bone Disorder - genetics | Vascular Calcification - metabolism | Kidney - metabolism | Bone Resorption - genetics | Bone and Bones - metabolism | Myocardium - metabolism | Renal Insufficiency, Chronic - genetics | Bone Resorption - metabolism | Disease Models, Animal | Bone Resorption - physiopathology | Glomerular Filtration Rate | Signal Transduction | Smad2 Protein - metabolism | Cardiomegaly - physiopathology | Nephritis, Hereditary - genetics | Renal Insufficiency, Chronic - physiopathology | Mice, Knockout | Renal Insufficiency, Chronic - prevention & control | Cardiomegaly - prevention & control | Nephritis, Hereditary - metabolism | Collagen Type IV - deficiency | Activin Receptors, Type II - genetics | Fibrosis | Sp7 Transcription Factor - metabolism | Collagen Type IV - genetics | Cardiomegaly - metabolism | Activin Receptors, Type II - metabolism | Bone and Bones - pathology | Phosphorylation | Vascular Remodeling | Blood Vessels - pathology | Vascular Calcification - genetics | Actins - metabolism | Chronic Kidney Disease-Mineral and Bone Disorder - physiopathology | Activin Receptors, Type II - antagonists & inhibitors | Blood Vessels - physiopathology | Renal Insufficiency, Chronic - metabolism | Ventricular Remodeling | Chronic Kidney Disease-Mineral and Bone Disorder - prevention & control | Muscle Proteins - metabolism | Vascular Calcification - physiopathology | Microfilament Proteins - metabolism | Nephritis, Hereditary - physiopathology | Kidney - physiopathology | Vascular Calcification - prevention & control | Myocardium - pathology | Bone Resorption - prevention & control | Bone and Bones - physiopathology | Animals | Nephritis, Hereditary - drug therapy | Cardiomegaly - genetics | Bone Remodeling | Chronic kidney disease
Journal Article
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2009, Volume 54, Issue 4, pp. 619 - 637
Background Phosphate binders are widely used to control serum phosphorus levels in patients with chronic kidney disease (CKD). We analyzed the effects of... 
Nephrology | chronic kidney disease | calcification | Phosphate binders | hyperphosphatemia | bone disease | LANTHANUM CARBONATE | SERUM PHOSPHORUS | CALCIUM-CARBONATE | CORONARY-ARTERY CALCIFICATION | DIALYSIS PATIENTS | HEMODIALYSIS-PATIENTS | MAINTENANCE HEMODIALYSIS | UROLOGY & NEPHROLOGY | CHRONIC KIDNEY-DISEASE | SEVELAMER HYDROCHLORIDE | CHRONIC-RENAL-FAILURE | Chronic Kidney Disease-Mineral and Bone Disorder - blood | Chronic Kidney Disease-Mineral and Bone Disorder - complications | Randomized Controlled Trials as Topic - methods | Humans | Polyamines - therapeutic use | Parathyroid Hormone - blood | Renal Insufficiency, Chronic - drug therapy | Calcium - blood | Calcium Compounds - adverse effects | Calcium Compounds - therapeutic use | Chronic Kidney Disease-Mineral and Bone Disorder - prevention & control | Renal Insufficiency, Chronic - mortality | Acetates - therapeutic use | Chronic Kidney Disease-Mineral and Bone Disorder - etiology | Sevelamer | Chelating Agents - therapeutic use | Lanthanum - therapeutic use | Bone Density Conservation Agents - therapeutic use | Calcium Carbonate - therapeutic use | Hypercalcemia - chemically induced | Biomarkers - blood | Calcium Compounds - administration & dosage | Renal Insufficiency, Chronic - blood | Phosphates - metabolism | Hyperphosphatemia - etiology | Phosphorus - blood | Hyperphosphatemia - drug therapy | Research Design | Index Medicus
Journal Article
Journal Article